Guidance Capital, Inc Neogenomics Inc Transaction History
Guidance Capital, Inc
- $327 Billion
- Q4 2024
A detailed history of Guidance Capital, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Guidance Capital, Inc holds 32,030 shares of NEO stock, worth $466,677. This represents 0.15% of its overall portfolio holdings.
Number of Shares
32,030Holding current value
$466,677% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$287 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$205 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$100 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$96.2 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$95.3 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.83B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...